Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Therapeutic Drug Monitoring
|
August 1, 1996
Individualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits
G Milano, M C Etienne
Pharmacogenetics
|
December 1, 1994
Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy
G Milano, M C Etienne
Anticancer Research
|
November 1, 1994
Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review)
G Milano, M C Etienne
La Revue De Medecine Interne
|
April 1, 1994
[Evolution from pharmacokinetics to pharmacogenetics. The example of 5-fluorouracil]
G Milano, M C Etienne
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1996
Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy
M C Etienne, T Guillot, G Milano
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide-N-oxide isomers in plasma
M C Etienne, W Oster, G Milano
Bulletin Du Cancer
|
May 1, 1993
[Clinical pharmacokinetics and practical consequences of optimal use of medroxyprogesterone acetate]
M C Etienne, G Milano, M Namer
Clinical Chemistry
|
January 1, 1993
HPLC of folinic acid diastereoisomers and 5-methyltetrahydrofolate in plasma
M C Etienne, N Speziale, G Milano
Annales De Gastroenterologie Et D'Hepatologie
|
March 1, 1995
[Intratumoral dihydropyrimidine dehydrogenase and its inhibition: a new approach in the pharmacokinetics of 5-fluorouracil]
G Milano, M C Etienne, J L Fischel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data
J L Fischel, M C Etienne, P Formento, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Therapeutic Drug Monitoring
|
August 1, 1996
Individualizing therapy with 5-fluorouracil related to dihydropyrimidine dehydrogenase: theory and limits
G Milano, M C Etienne
Pharmacogenetics
|
December 1, 1994
Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy
G Milano, M C Etienne
Anticancer Research
|
November 1, 1994
Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review)
G Milano, M C Etienne
La Revue De Medecine Interne
|
April 1, 1994
[Evolution from pharmacokinetics to pharmacogenetics. The example of 5-fluorouracil]
G Milano, M C Etienne
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1996
Critical factors for optimizing the 5-fluorouracil-folinic acid association in cancer chemotherapy
M C Etienne, T Guillot, G Milano
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide-N-oxide isomers in plasma
M C Etienne, W Oster, G Milano
Bulletin Du Cancer
|
May 1, 1993
[Clinical pharmacokinetics and practical consequences of optimal use of medroxyprogesterone acetate]
M C Etienne, G Milano, M Namer
Clinical Chemistry
|
January 1, 1993
HPLC of folinic acid diastereoisomers and 5-methyltetrahydrofolate in plasma
M C Etienne, N Speziale, G Milano
Annales De Gastroenterologie Et D'Hepatologie
|
March 1, 1995
[Intratumoral dihydropyrimidine dehydrogenase and its inhibition: a new approach in the pharmacokinetics of 5-fluorouracil]
G Milano, M C Etienne, J L Fischel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data
J L Fischel, M C Etienne, P Formento, et al.
Page
of 10